399 related articles for article (PubMed ID: 21151616)
1. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.
Kee HJ; Kook H
J Biomed Biotechnol; 2011; 2011():928326. PubMed ID: 21151616
[TBL] [Abstract][Full Text] [Related]
2. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
[TBL] [Abstract][Full Text] [Related]
3. CaMKII exacerbates heart failure progression by activating class I HDACs.
Zhang M; Yang X; Zimmerman RJ; Wang Q; Ross MA; Granger JM; Luczak ED; Bedja D; Jiang H; Feng N
J Mol Cell Cardiol; 2020 Dec; 149():73-81. PubMed ID: 32971072
[TBL] [Abstract][Full Text] [Related]
4. Heart failure: the pivotal role of histone deacetylases.
Hewitson R; Dargan J; Collis D; Green A; Moorjani N; Ohri S; Townsend PA
Int J Biochem Cell Biol; 2013 Feb; 45(2):448-53. PubMed ID: 23178536
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors.
Han Y; Nie J; Wang DW; Ni L
Front Cardiovasc Med; 2022; 9():931475. PubMed ID: 35958418
[TBL] [Abstract][Full Text] [Related]
6. Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy.
Kee HJ; Eom GH; Joung H; Shin S; Kim JR; Cho YK; Choe N; Sim BW; Jo D; Jeong MH; Kim KK; Seo JS; Kook H
Circ Res; 2008 Nov; 103(11):1259-69. PubMed ID: 18849323
[TBL] [Abstract][Full Text] [Related]
7. The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy.
Oka S; Ago T; Kitazono T; Zablocki D; Sadoshima J
J Mol Med (Berl); 2009 Aug; 87(8):785-91. PubMed ID: 19424677
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy.
Raghunathan S; Goyal RK; Patel BM
Can J Physiol Pharmacol; 2017 Mar; 95(3):260-267. PubMed ID: 28177689
[TBL] [Abstract][Full Text] [Related]
9. Non-sirtuin histone deacetylases in the control of cardiac aging.
Ferguson BS; McKinsey TA
J Mol Cell Cardiol; 2015 Jun; 83():14-20. PubMed ID: 25791169
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylases as therapeutic targets--from cancer to cardiac disease.
Abend A; Kehat I
Pharmacol Ther; 2015 Mar; 147():55-62. PubMed ID: 25444758
[TBL] [Abstract][Full Text] [Related]
11. Role of histone deacetylase 2 and its posttranslational modifications in cardiac hypertrophy.
Eom GH; Kook H
BMB Rep; 2015 Mar; 48(3):131-8. PubMed ID: 25388210
[TBL] [Abstract][Full Text] [Related]
12. [The mechanism underlying histone deacetylases regulating cardiac hypertrophy].
Ren L; Wu XS; Li YQ
Yi Chuan; 2020 Jun; 42(6):536-547. PubMed ID: 32694112
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications.
Wang Z; Zhao YT; Zhao TC
Exp Biol Med (Maywood); 2021 Jan; 246(2):213-225. PubMed ID: 32727215
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2.
Jayathilaka N; Han A; Gaffney KJ; Dey R; Jarusiewicz JA; Noridomi K; Philips MA; Lei X; He J; Ye J; Gao T; Petasis NA; Chen L
Nucleic Acids Res; 2012 Jul; 40(12):5378-88. PubMed ID: 22396528
[TBL] [Abstract][Full Text] [Related]
15. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity.
Trivedi CM; Luo Y; Yin Z; Zhang M; Zhu W; Wang T; Floss T; Goettlicher M; Noppinger PR; Wurst W; Ferrari VA; Abrams CS; Gruber PJ; Epstein JA
Nat Med; 2007 Mar; 13(3):324-31. PubMed ID: 17322895
[TBL] [Abstract][Full Text] [Related]
16. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy.
Zhang CL; McKinsey TA; Chang S; Antos CL; Hill JA; Olson EN
Cell; 2002 Aug; 110(4):479-88. PubMed ID: 12202037
[TBL] [Abstract][Full Text] [Related]
17. Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms.
Weeks KL; Avkiran M
J Physiol; 2015 Apr; 593(8):1785-97. PubMed ID: 25362149
[TBL] [Abstract][Full Text] [Related]
18. Targeting histone deacetylases for heart failure.
Bush EW; McKinsey TA
Expert Opin Ther Targets; 2009 Jul; 13(7):767-84. PubMed ID: 19466913
[TBL] [Abstract][Full Text] [Related]
19. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases.
Eom GH; Kook H
Pharmacol Ther; 2014 Aug; 143(2):168-80. PubMed ID: 24594235
[TBL] [Abstract][Full Text] [Related]
20. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
